tanshinone has been researched along with Diabetic Nephropathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, YB; Li, L; Wu, Q; Zhang, KJ; Zhou, Y | 1 |
| Cai, K; Duan, JA; Liu, F; Su, SL; Xu, Z; Zhu, Y | 1 |
| Cheng, D; Kong, AN; Li, S; Li, W; Sargsyan, D; Wang, L; Wu, R | 1 |
| Ding, K; He, L; Qian, X; Wang, S; Xu, S; Xu, X; Zhang, L | 1 |
| Chen, X; Dai, D; Gao, Y; Ge, S; Kong, Y; Liu, Q; Lu, Z; Sun, D; Wang, F; Wang, N; Wu, R; Yang, Y | 1 |
| Chen, G; Li, C; Lin, Y; Meng, Y; Tang, S; Zhang, X | 1 |
| Jung, KH; Kim, SK; Lee, BC | 1 |
7 other study(ies) available for tanshinone and Diabetic Nephropathies
| Article | Year |
|---|---|
Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Endothelial Cells; Glucose; Humans; Inflammasomes; Mice; Mice, Inbred Strains; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pyroptosis; Reactive Oxygen Species | 2023 |
Salvianolic acid B and tanshinone IIA synergistically improve early diabetic nephropathy through regulating PI3K/Akt/NF-κB signaling pathway.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Glucose; Inflammation; Nephritis; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2024 |
DNA Methylome and Transcriptome Alterations in High Glucose-Induced Diabetic Nephropathy Cellular Model and Identification of Novel Targets for Treatment by Tanshinone IIA.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Diabetic Nephropathies; Disease Models, Animal; DNA Methylation; Glucose; Inflammation; Mice; Molecular Structure; Oxidative Stress; Transcriptome | 2019 |
Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis.
Topics: Abietanes; Animals; Diabetic Nephropathies; eIF-2 Kinase; Endoplasmic Reticulum Stress; Fibrosis; Hypoglycemic Agents; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin | 2020 |
Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation.
Topics: Abietanes; Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Inflammation; Inflammation Mediators; Kidney Function Tests; Male; Oxidative Stress; Rats | 2017 |
Role of the TGFβ/p65 pathway in tanshinone ⅡA-treated HBZY‑1 cells.
Topics: Abietanes; Animals; Cell Line; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Neoplasm Proteins; Nucleocytoplasmic Transport Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; Transforming Growth Factor beta | 2014 |
Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy.
Topics: Abietanes; Angiotensin II; Animals; Blood Glucose; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Immunohistochemistry; Kidney; Macrophages; Monocytes; Neutrophil Infiltration; Phenanthrenes; Protective Agents; Proteinuria; Rats; Transforming Growth Factor beta1 | 2009 |